Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Angelova, Assia L.
62  Ergebnisse:
?
1

H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment..:

Angelova, Assia ; Barf, Milena ; Just, Alexandra...
Cancers.  16 (2024)  15 - p. 2711 , 2024
Link: https://doi.org/10.3390/..
 
?
2

The Complex Role of Infectious Agents in Human Cutaneous T-..:

Angelova, Assia ; Rommelaere, Jean ; Ungerechts, Guy
Pathogens.  13 (2024)  3 - p. 184 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Ind..:

Angelova, Assia ; Pierrard, Kristina ; Detje, Claudia N....
Pathogens.  12 (2023)  4 - p. 607 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Generation and Validation of Monoclonal Antibodies Suitable..:

Tessmer, Claudia ; Plotzky, Claudia ; Fees, Jana...
Pathogens.  11 (2022)  2 - p. 208 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Parvovirus-Based Combinatorial Immunotherapy: A Reinforced ..:

Angelova, Assia ; Ferreira, Tiago ; Bretscher, Clemens..
Cancers.  13 (2021)  2 - p. 342 , 2021
Link: https://doi.org/10.3390/..
 
?
6

Virotherapy in Germany—Recent Activities in Virus Engineeri..:

Nettelbeck, Dirk M. ; Leber, Mathias F. ; Altomonte, Jennifer...
Viruses.  13 (2021)  8 - p. 1420 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Immune System Stimulation by Oncolytic Rodent Protoparvovir..:

Angelova, Assia ; Rommelaere, Jean
Viruses.  11 (2019)  5 - p. 415 , 2019
Link: https://doi.org/10.3390/..
 
?
8

Immune Conversion of Tumor Microenvironment by Oncolytic Vi..:

Marchini, Antonio ; Daeffler, Laurent ; Pozdeev, Vitaly I...
Frontiers in Immunology.  10 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
9

Tailoring acyclovir prodrugs with enhanced antiviral activi..:

Chayrov, Radoslav L. ; Stylos, Evgenios K. ; Chatziathanasiadou, Maria V....
Amino Acids.  50 (2018)  8 - p. 1131-1143 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hi..:

Angelova, Assia ; Barf, Milena ; Geletneky, Karsten..
Viruses.  9 (2017)  12 - p. 382 , 2017
Link: https://doi.org/10.3390/..
 
?
11

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunoge..:

Geletneky, Karsten ; Hajda, Jacek ; Angelova, Assia L....
Molecular Therapy.  25 (2017)  12 - p. 2620-2634 , 2017
Link: https://doi.org/10.1016/..
 
?
12

A non-controlled, single arm, open label, phase II study of..:

Hajda, Jacek ; Lehmann, Monika ; Krebs, Ottheinz...
BMC Cancer.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
13

The Oncolytic Virotherapy Era in Cancer Management: Prospec..:

Angelova, Assia L. ; Witzens-Harig, Mathias ; Galabov, Angel S..
Frontiers in Oncology.  7 (2017)  - p. , 2017
Link: https://doi.org/10.3389/..
 
?
14

Tumor Selectivity of Oncolytic Parvoviruses: From in vitro ..:

Angelova, Assia L. ; Geletneky, Karsten ; Nüesch, Jürg P. F..
Frontiers in Bioengineering and Biotechnology.  3 (2015)  - p. , 2015
Link: https://doi.org/10.3389/..
 
?
15

ATNT-07FAVORABLE RESPONSE OF PATIENTS WITH GLIOBLASTOMA AT ..:

Geletneky, Karsten ; Angelova, Assia ; Leuchs, Barbara...
Neuro-Oncology.  17 (2015)  suppl 5 - p. v11.3-v11 , 2015
Link: https://doi.org/10.1093/..
 
1-15